Interstitial keratitis secondary to severe hidradenitis suppurativa responding to adalimumab

Cornea

Volumn 31, Issue 2, 2012, Pages 206-

  Blanco, Ricardo ^a   González Vela, M Carmen ^a   González López, Marcos A ^a   Fernández Llaca, Héctor ^a   Cañal, Joaquin ^a   González Gay, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB;

DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; FOLLOW UP; HUMAN; INTERSTITIAL KERATITIS; KERATITIS; LETTER; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REMISSION; SUPPURATIVE HIDRADENITIS; TREATMENT RESPONSE;

FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; KERATITIS;

EID: 84855841733     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31820ce137     Document Type: Letter

References (7)

1. Alzaga Fernandez AG, Demirci H, Darnley-Fisch DA, et al. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review. Cornea. 2010 [epub ahead of print].
2. Moul DK, Korman NJ. Severe hidradenitis suppurativa treated with adalimumab. Arch Dermatol. 2006;142:1110-1112. (Pubitemid 44414393)
3. Scheinfeld N. Treatment of coincident seronegative arthritis and hidradenitis suppurativa with adalimumab. J Am Acad Dermatol. 2006;55: 163-164. (Pubitemid 43867032)
4. Yamauchi P, Mau N. Hidradenitis suppurativa managed with adalimumab. J Drugs Dermatol. 2009;8:181-183.
5. Blanco R, Martinez-Taboada VM, Villa I, et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol. 2009;145:580-584.
6. Reddick CL, Singh MN, Chalmers RJG. Letter: successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab. Dermatol Online J. 2010;16:15.
7. Amano M, Grant A, Kerdel FA. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. Int J Dermatol. 2010 [epub ahead of print].